GABA released from cultured cortical neurons influences the modulation of t-[35S]butylbicyclophosphorothionate binding at the GABAA receptor. Effects of thymol

European Journal of Pharmacology

Volumn 600, Issue 1-3, 2008, Pages 26-31

  García, Daniel A ^a,c   Vendrell, Iolanda ^a,b   Galofré, Mireia ^a,b   Suñol, Cristina ^a,b  

^a INSTITUT D INVESTIGACIONS BIOMÈDIQUES AUGUST PI I SUNYER IDIBAPS   (Spain)

^b CIBER EPIDEMIOLOGÍA Y SALUD PÚBLICA CIBERESP   (Spain)

^c UNIVERSIDAD NACIONAL DE CÓRDOBA   (Argentina)

Author keywords

35S TBPS binding; Buffer effect, Neuronal GABA transporter; Chloride uptake; GABA release; GABAA receptor; Thymol

Indexed keywords

1 (4,4 DIPHENYL 3 BUTENYL)GUVACINE; 4 (2 HYDROXYETHYL) 1 PIPERAZINEETHANESULFONIC ACID; 4 AMINOBUTYRIC ACID; 4 AMINOBUTYRIC ACID A RECEPTOR; CHLORIDE; PICROTOXININ; PROPOFOL; SODIUM CHLORIDE; TERT BUTYLBICYCLOPHOSPHOROTHIOATE; THYMOL;

ANIMAL CELL; ARTICLE; BRAIN CELL; CELL CULTURE; CELL VIABILITY; CHLORIDE TRANSPORT; CONCENTRATION RESPONSE; FEMALE; FETUS; MOLECULAR RECOGNITION; MOUSE; NEUROTRANSMITTER RELEASE; NONHUMAN; PRIORITY JOURNAL; RECEPTOR BINDING;

ALLOSTERIC REGULATION; ANESTHETICS, INTRAVENOUS; ANIMALS; BICYCLO COMPOUNDS, HETEROCYCLIC; BINDING SITES; BINDING, COMPETITIVE; CELL SURVIVAL; CELLS, CULTURED; CEREBRAL CORTEX; CHLORIDES; GAMMA-AMINOBUTYRIC ACID; MICE; PROPOFOL; RECEPTORS, GABA-A; THYMOL;

EID: 55949083383     PISSN: 00142999     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ejphar.2008.10.013     Document Type: Article

References (42)

1. A receptors and niflumic acid-sensitive chloride channels. Eur. J. Neurosci. 21 (2005) 103-112
2. A receptor. Mol. Pharmacol. 65 (2004) 68-76
3. Burt S. Essential oils: their antibacterial properties and potential applications in foods - a review. Int. J. Food Microbiol. 94 (2004) 223-253
4. Clausen R.P., Frølund B., Larsson O.M., Schousboe A., Krogsgaard-Larsen P., and White H.S. A novel selective γ-aminobutyric acid transport inhibitor demonstrates a functional role for GABA transporter subtype GAT2/BGT-1 in the CNS. Neurochem. Int. 48 (2006) 637-642
5. A receptor suggest a similar mechanism of action. Can. J. Physiol. Pharm. 76 (1998) 46-52
6. Frandsen A., and Schousboe A. Development of excitatory amino acid induced cytotoxicity in cultured neurons. Int. J. Dev. Neurosci. 8 (1990) 209-216
7. A receptor in primary cultures of mouse cortical neurons. Neuropharmacology 50 (2006) 25-35
8. Gether U., Andersen P.H., Larsson O.M., and Schousboe A. Neurotransmitter transporters: molecular function of important drug targets. Trends Pharmacol. Sci. 27 (2006) 375-383
9. A receptor in rat brain. Biochem. Pharmacol. 51 (1996) 1527-1534
10. A receptors: views from outside the synaptic cleft. Neuron 56 (2007) 763-770
11. Gomes-Carneiro M.R., Felzenszwalb I., and Paumgartten F.J. Mutagenicity testing (+/-)-camphor, 1,8-cineole, citral, citronellal, (-)-menthol and terpineol with the Salmonella/microsome assay. Mutat. Res. 416 (1998) 129-136
12. Haeseler G., Maue D., Grosskreutz J., Bufler J., Nentwig B., Piepenbrock S., Dengler R., and Leuwer M. Voltage-dependent block of neuronal and skeletal muscle sodium channels by thymol and menthol. Eur. J. Anaesthesiol. 19 (2002) 571-579
13. Hawkinson J.E., Acosta-Burruel M., Yang K.C., Hogenkamp D.J., Chen J.S., Lan N.C., Drewe J.A., Whittemore E.R., Woodward R.M., Carter R.B., and Upasani R.B. Substituted 3β-phenylethynyl derivatives of 3α-hydroxy-5α-pregnan-20-one: remarkably potent neuroactive steroid modulators of γ-aminobutyric acid A receptors. J. Pharmacol. Exp. Ther. 287 (1998) 198-207
14. A receptor-channel complex in rat dorsal root ganglion neurons. Toxicol. Appl. Pharmacol. 140 (1996) 508-520
15. A receptor subtypes. Br. J. Pharmacol. 112 (1994) 1025-1030
16. Kalueff A.V. Mapping convulsants' binding to the GABA-A receptor chloride ionophore: a proposed model for channel binding sites. Neurochem. Int. 50 (2007) 61-68
17. A receptor. J. Med. Chem. 45 (2002) 3210-3221
18. Lee S.P., Buber M.T., Yang Q., Cerne R., Cortés R.Y., Sprous D.G., and Bryant R.W. Thymol and related alkyl phenols activate the hTRPA1 channel. Brit. J. Pharmacol. 153 (2008) 1739-1749
19. Li L.B., Cui X.N., and Reith M.A. Is Na+ required for the binding of dopamine, amphetamine, tyramine, and octopamine to the human dopamine transporter?. Naunyn Schmiedebergs Arch. Pharmacol. 365 (2002) 303-311
20. A receptor channels. Annu. Rev. Neurosci. 17 (1994) 569-602
21. MacPherson R.D. Pharmaceutics for the anaesthetist. Anaesthesia 56 (2001) 965-979
22. McKernan R.M., and Whiting P.J. Which GABA,-receptor subtypes really occur in the brain?. Trends Neurosci. 19 (1996) 139-143
23. A receptors. Eur. J. Pharmacol. 421 (2001) 85-91
24. A receptors exhibiting different levels of spontaneous activity. Eur. J. Pharm. 476 (2003) 17-24
25. 35S]butylbicyclophosphorothionate binding by convulsant agents in primary cultures of cerebellar neurons. Dev. Brain Res. 73 (1993) 85-90
26. A receptors and a homo-oligomeric GABA receptor from Drosophila melanogaster. Br. J. Pharmacol. 14 (2003) 1363-1372
27. Risso S., DeFelice L.J., and Blakely R.D. Sodium-dependent GABA-induced currents in GATI-transfected HeLa cells. J. Physiol. 490 (1996) 691-702
28. Sánchez M.E., Turina A.V., García D.A., Nolan M.V., and Perillo M.A. Surface activity of thymol: implications for an eventual pharmacological activity. Colloids Surf. B 34 (2004) 77-85
29. Shapiro S., and Guggenheim B. The action of thymol on oral bacteria. Oral Microbiol. Immunol. 10 (1995) 241-246
30. Spence I., Drew C., Johnston G.A., and Lodge D. Acute effects of lead at central synapses in vitro. Brain Res. 333 (1985) 103-109
31. A receptor complexes in rat forebrain: implications for schizophrenia and clozapine research. Neurochem. Res. 25 (2000) 1587-1601
32. 35S]t-butylbicyclophosphorothionate binds with high affinity to brain-specific sites coupled to γ-aminobutyric acid-A and ion recognition sites. Mol. Pharmacol. 23 (1983) 326-336
33. A receptor in primary neuronal cultures. J. Med. Chem. 49 (2006) 3225-3234
34. Suñol C., Babot Z., Fonfría E., Galofré M., García D., Herrera N., Iraola S., and Vendrell I. Studies with neuronal cells: from basic studies of mechanisms of neurotoxicity to the prediction of chemical toxicity. Toxicol. In Vitro 22 (2008) 1350-1355
35. 35S]-t-butylbicyclophosphorothionate binding sites are constituents of the gamma-aminobutyric acid benzodiazepine receptor complex. J. Neurosci. 4 (1984) 1193-1200
36. 35S]TBPS binding. Neurochem. Res. 29 (2004) 771-780
37. Vale C., Pomés A., Rodríguez-Farré E., and Suñol C. Allosteric interactions between γ-aminobutyric acid, benzodiazepine and picrotoxinin binding sites in primary cultures of cerebellar granule cells. Differential effects induced by γ- and δ-hexachlorocyclohexanes. Eur. J. Pharmacol. 319 (1997) 343-353
38. Vale C., Vilaro M.T., Rodriguez-Farre E., and Suñol C. Effects of the conformationally restricted GABA analogues, cis- and trans-4-aminocrotonic acid, on GABA neurotransmission in primary neuronal cultures. J. Neurosci. Res. 57 (1999) 95-105
39. A and glycine-gated chloride channels in primary cultures of cerebellar granule cells. Neurosci. 37 (2003) 397-403
40. A receptor subtypes in the brain: a paradigm for CNS drug discovery?. Drug Discov. Today 8 (2003) 445-450
41. A receptors. Eur. J. Neurosci. 9 (1997) 2225-2235
42. Zeng C.M., Manion B.D., Benz A., Evers A.S., Zorumski C.F., Mennerick S., and Covey D.F. Neurosteroid analogues. 10. The effect of methyl group substitution at the C-6 and C-7 positions on the GABA modulatory and anesthetic actions of (3α,5α)- and (3α,5ββ)-3-hydroxypregnan-20-one. J. Med. Chem. 48 (2005) 3051-3059